Rosiglitazone Promotes Microglial Distribution via Activation of PPARγ and CD36 in the ICH Rat Model.

Qiong MuQian HeHailong ZhouYingning XuGuofeng Wu

Published in: Neuro endocrinology letters (2024)

Rosiglitazone may improve microglial distribution via promoting the expression of PPARγ and CD36 around the hematoma in the ICH rat model, which may provide effective therapeutic targets for the treatment of ICH.

Keyphrases

inflammatory response
lipopolysaccharide induced
lps induced
insulin resistance
poor prognosis
neuropathic pain
nk cells
fatty acid
binding protein
spinal cord injury
adipose tissue
metabolic syndrome
long non coding rna
skeletal muscle
replacement therapy